SchimpffSCMoodyMYoungVM.Relationship of colonisation with Pseudomonas aeruginosa to development of Pseudomonas bacteraemia in cancer patients. In: HobbyGL, ed. Antimicrob Agents Chemotherapy 1970. Washington DC: American Society for Microbiology, 1971:240.
2.
HuangNNDoggettRG.Antibiotic therapy of Pseudomonas infection in patients with cystic fibrosis. In: DoggettRD, ed. Pseudomonas aeruginosa. New York: Academic Press, 1979:409.
3.
HermaszewskiRAWebsterAD.Primary hypogamma-globulinaemia: A survey of clinical manifestations and complications. Q J Med1993;86(1):31–42.
4.
KeilhofnerMAtmarRLHamilRJMusherDM.Life-threatening Pseudomonas aeruginosa infections in patients with Human Immunodeficiency virus infection. Clin Infect Dis1992;14(2):403–11.
5.
BaronADHollanderH.Pseudomonas aeruginosa bronchopulmonary infection in late Human Immunodeficiency virus disease. Am Rev Respir Dis1993;148:992–6.
6.
SzaffMHoibyNFlensbergEW.Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand1983;72:821–6.
7.
ParkinJMHelbertMHughesCLPinchingAJ.Immunoglobulin subclass deficiency and susceptibility to pyogenic infections in patients with AIDS-related complex and AIDS. AIDS1989;3:37–9.
8.
The National Institute of Child health and Human Development Intravenous Immunoglobulin Study Group. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic immunodeficiency syndrome. N Engl J Med1991;325(2):74–80.
9.
Saint-MarcTTouraineJ-LBerraN.Beneficial effects of intravenous immunoglobulins in AIDS. Lancet1992;340:1347.
